References
Medzhitov, R., 2008. Origin and physiological roles of inflammation. Nature, 454(7203), pp.428-435.
Franceschi, C., Bonafè, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E. and De Benedictis, G., 2000. Inflamm‐aging: an evolutionary perspective on immunosenescence. Annals of the new York Academy of Sciences, 908(1), pp.244-254.
DrJokers, What Causes inflammation? & Key Contributors. (online) Available at: https://drjockers.com/causes-inflammation/ (Accessed: 07/10/2026).
Donath, M.Y. and Shoelson, S.E., 2011. Type 2 diabetes as an inflammatory disease. Nature reviews immunology, 11(2), pp.98-107.
Libby, P., 2021. The changing landscape of atherosclerosis. Nature, 592(7855), pp.524-533.
6 Barnes, P.J., 2016. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology, 138(1), pp.16-27.
McInnes, I.B. and Schett, G., 2011. The pathogenesis of rheumatoid arthritis. New England journal of medicine, 365(23), pp.2205-2219.
Greten, F.R. and Grivennikov, S.I., 2019. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity, 51(1), pp.27-41.
Heneka, M.T., Carson, M.J., El Khoury, J., Landreth, G.E., Brosseron, F., Feinstein, D.L., Jacobs, A.H., Wyss-Coray, T., Vitorica, J., Ransohoff, R.M. and Herrup, K., 2015. Neuroinflammation in Alzheimer's disease. The Lancet Neurology, 14(4), pp.388-405.
Osimo, E.F., Baxter, L.J., Lewis, G., Jones, P.B. and Khandaker, G.M., 2019. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychological medicine, 49(12), pp.1958-1970.
11 DrJokers, What Causes inflammation? & Key Contributors. (online) Available at: https://drjockers.com/causes-inflammation/ (Accessed: 07/10/2026).
BBC, 2026. Is inflammation behind all chronic disease? (Online) Available at: https://www.bbc.co.uk/sounds/play/m002zggr (Accessed: 03/09/2026).
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D.W., Fasano, A., Miller, G.W. and Miller, A.H., 2019. Chronic inflammation in the etiology of disease across the life span. Nature medicine, 25(12), pp.1822-1832.
Nikolich-Žugich, J., 2018. The twilight of immunity: emerging concepts in aging of the immune system. Nature immunology, 19(1), pp.10-19.
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D.W., Fasano, A. and Miller, G.W., Chronic inflammation in the etiology of disease across the life span., 2019, 25. DOI: https://doi. org/10.1038/s41591-019-0675-0, pp.1822-1832.
16 Donath, M.Y. and Shoelson, S.E., 2011. Type 2 diabetes as an inflammatory disease. Nature reviews immunology, 11(2), pp.98-107.
Hotamisligil, G.S., 2017. Inflammation, metaflammation and immunometabolic disorders. Nature, 542(7640), pp.177-185.
Lackey, D.E. and Olefsky, J.M., 2016. Regulation of metabolism by the innate immune system. Nature Reviews Endocrinology, 12(1), pp.15-28.
Ying, W., Fu, W., Lee, Y.S. and Olefsky, J.M., 2020. The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities. Nature Reviews Endocrinology, 16(2), pp.81-90.
Adkar, S.S. and Leeper, N.J., 2024. Efferocytosis in atherosclerosis. Nature Reviews Cardiology, 21(11), pp.762-779.
21 Bäck, M., Yurdagul Jr, A., Tabas, I., Öörni, K. and Kovanen, P.T., 2019. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nature Reviews Cardiology, 16(7), pp.389-406.
NIH, 2022. Targeting Inflammation Emerges as a Strategy for Treating Cancer (online) Available at: https://www.cancer.gov/news-events/cancer-currents-blog/2022/reducing-inflammation-to-treat-cancer?utm (Accessed: 30/09/2026)
Pittet, M.J., Michielin, O. and Migliorini, D., 2022. Clinical relevance of tumour-associated macrophages. Nature reviews Clinical oncology, 19(6), pp.402-421.
Noack, M. and Miossec, P., 2021. Importance of lymphocyte–stromal cell interactions in autoimmune and inflammatory rheumatic diseases. Nature Reviews Rheumatology, 17(9), pp.550-564.
Heneka, M.T., Van der Flier, W.M., Jessen, F., Hoozemanns, J., Thal, D.R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A.H. and Edison, P., 2025. Neuroinflammation in Alzheimer disease. Nature Reviews Immunology, 25(5), pp.321-352.
26 Lorenz, T., Michels, N., Slavich, G.M. and Giletta, M., 2025. Examining systemic inflammation as a pathway linking peer victimization to depressive symptoms in adolescence. Journal of Child Psychology and Psychiatry, 66(3), pp.311-321.
Yuan, N., Chen, Y., Xia, Y., Dai, J. and Liu, C., 2019. Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses. Translational psychiatry, 9(1), p.233.
Garg, S. and McCullough, L.D., 2026. Vascular cognitive impairment and dementia: current understanding and future directions. npj Dementia, 2(1), p.81.
Norcliffe, D., Manuel, D., Benson, B., 2025. CRP, ESR and PV Inflammation Markers - a Comparative Review (Online) Available at: https://content.yudu.com/web/1u0jl/0A1v7oc/PiP-May-2025/html/index.html?page=14&origin=reader (Accessed: 07/09/2029).
Harkness, J., 1981. Measurement of plasma viscosity. In Clinical aspects of blood viscosity and cell deformability (pp. 79-87). London: Springer London.
31 Nichols, E., Steinmetz, J.D., Vollset, S.E., Fukutaki, K., Chalek, J., Abd-Allah, F., Abdoli, A., Abualhasan, A., Abu-Gharbieh, E., Akram, T.T. and Al Hamad, H., 2022. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public Health, 7(2), pp.e105-e125.
NHS, children’s Healthier Eating Toolkit. (Online) Available at: https://assets.nhs.uk/campaign-resource-centre-v3-production/documents/13.12.21_Better_Health-Childrens_Healthier_Eating_Toolkit.pdf (Accessed: 06/10/2026).
Plasma Viscosity, 2025. (Online) Available at: https://www.gloshospitals.nhs.uk/our-services/services-we-offer/pathology/tests-and-investigations/plasma-viscosity/ (Accessed: 13/10/2026).
Peters, S.A., Woodward, M., Rumley, A., Tunstall-Pedoe, H.D. and Lowe, G.D., 2017. Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish Heart Health Extended Cohort Study. European journal of preventive cardiology, 24(2), pp.161-167.
Aras, S., Tek, I., Varli, M., Yalcin, A., Cengiz, O.K., Atmis, V. and Atli, T., 2013. Plasma Viscosity: Is a Biomarker for the Differential Diagnosis of Alzheimer’s Disease and Vascular Dementia?. American Journal of Alzheimer's Disease & Other Dementias®, 28(1), pp.62-68.
36 Gleghorn, D.M., Olayiwola, O., Omer, A., Lynn, R., Norcliffe, D. and Robinson, M., 2021. Diagnostic value of plasma viscosity testing for patients with COVID‐19. International Journal of Laboratory Hematology, 43(4), p.O227.
Gudmundsson, M. and Bjelle, A., 1995. Plasma viscosity in the monitoring of therapy in rheumatoid arthritis patients. Scandinavian journal of rheumatology, 24(4), pp.219-224.